NAD+ serves as an essential coenzyme for hundreds of enzymatic reactions, including those involved in energy production, DNA repair, and cellular signaling
This repositions GLP-1 receptor agonists like semaglutide 2.4 mg as true cardiometabolic therapies rather than just anti-obesity drugs
This is the first head-to-head Phase 3 clinical trial result comparing these two leading weight loss medications, providing clearer data on their relative effectiveness
However, clinical evidence remains conflicting and highly debated, highlighting the importance of comprehensively characterizing GLP-1R expression in both primary and metastatic thyroid cancers
By triggering GLP-1 and GIP receptors in other tissues, tirzepatide also slows down digestion and suppresses appetite, helping patients achieve significant weight reduction [6, 7, 8]
We can also provide a superbill that patients can submit to their insurance provider for potential reimbursement or out-of-network deductible credit